ChromaDex, Inc. Introduces NIAGEN™ - the First and Only Commercially Available Nicotinamide Riboside
5/29/2013 10:06:56 AM
More...
|
ChromaDex, Inc. to Present at the Second Annual Marcum LLP MicroCap Conference
5/20/2013 6:20:30 AM
More...
|
ChromaDex, Inc. Reports Results for the First Quarter 2013
5/10/2013 7:13:50 AM
More...
|
ChromaDex, Inc. Initiates First Human Clinical Study for Its New Caffeine Ingredient Technology, PURENERGY™
4/18/2013 9:33:40 AM
More...
|
ChromaDex, Inc. CEO to Chair Conference Session on Quality Control for Dietary Supplements
4/15/2013 6:28:34 AM
More...
|
ChromaDex, Inc. Introduces New Caffeine Ingredient Technology, PURENERGY™
4/1/2013 9:41:30 AM
More...
|
ChromaDex, Inc. Reports 2012 Full-Year Results and Closes Strategic Sale of Its BluScience™ Consumer Product Line
4/1/2013 9:28:11 AM
More...
|
ChromaDex, Inc. to Present at 25th Annual ROTH Conference on March 19, 2013
3/13/2013 7:02:16 AM
More...
|
ChromaDex, Inc. Adds to Its Exclusive Worldwide Patent Rights for Nicotinamide Riboside (NR) With Washington University Agreement
3/8/2013 9:36:58 AM
More...
|
ChromaDex, Inc. Plans Strategic Sale of its BluScience™ Consumer Product Line to NeutriSci International
2/25/2013 11:15:06 AM
More...
|
|